RankingsPricing
  1. US-listed companies
  2. AMGEN INC
  3. Financials
  4. Diluted EPS

AMGEN INCAMGN

Market cap
$175.3B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 20247.6-39.47%
Dec 31, 202312.5+3.14%
Dec 31, 202212.1+17.80%
Dec 31, 202110.3-16.49%
Dec 31, 202012.3-4.43%
Dec 31, 201912.9+2.06%
Dec 31, 201812.6+369.14%
Dec 31, 20172.7-73.73%
Dec 31, 201610.2+13.02%
Dec 31, 20159.1+35.22%
Dec 31, 20146.7+0.90%
Dec 31, 20136.6+20.29%
Dec 31, 20125.5+36.63%
Dec 31, 20114-15.66%
Dec 31, 20104.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)